[Sounding the call for functional cure of hepatitis B and opening a new era of combination therapy]. [PDF]
Cheng C, Liang XE, Liu ZH, Hou JL.
europepmc +1 more source
[Occurrence risk of extrahepatic liver tumor with hepatitis B virus infection]. [PDF]
Zhao DL, Wei L.
europepmc +1 more source
[Comparison of antiviral efficacy of nucleos(t)ide analogue monotherapy and its combination with interferon-α in children 1-6 years-old with HBeAg-positive chronic hepatitis B]. [PDF]
Wang ZW +11 more
europepmc +1 more source
[Reflections on the novel definition and whether or not antiviral therapy for inactive HBsAg carrier state in the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)"]. [PDF]
Ren S, Zheng SJ, Chen XY.
europepmc +1 more source
[Controversy and consensus on antiviral treatment strategies for low-level hepatitis B surface antigens]. [PDF]
Hou YH, Zhang LY.
europepmc +1 more source
[Research progress on new drugs for the treatment of chronic hepatitis B virus infection]. [PDF]
Yu YY, Li J, Wang WX, Fan PY, Wang FS.
europepmc +1 more source
[Introduction of the key update points of the 2025 Canadian Association for the Study of the Liver guideline for the management of chronic hepatitis B]. [PDF]
Zhuang H.
europepmc +1 more source
[A case of hepatitis B surface antigen clearance achievement based on the combination of interferon and intermittent consolidation therapy]. [PDF]
Deng W +5 more
europepmc +1 more source
[Expert recommendations on hepatitis B vaccination in adults]. [PDF]
Working Committee of Promoting the Elimination of Viral Hepatitis of Chinese Preventive Medicine Association +1 more
europepmc +1 more source
[A case of chronic hepatitis B in the treatment of tenofovir amibufenamide]. [PDF]
Li J, Fu MY, Zhu YF.
europepmc +1 more source

